One of 7investing's key principles is to think longer-term. There's a lot of short-term noise in the market, which causes significant volatility in stock prices. Patient investors who can tune this noise out and focus on the bigger picture have an excellent chance of improving their long-term returns. There is also significant volatility in the world of cryptocurrencies. Traders obsess over the daily price of Bitcoin, rather than focusing instead of the growing global adoption of blockchains. So...
Aug 19, 2021•37 min•Season 2Ep. 120
The stock market fell on Tuesday after reaching an all-time high Monday. Investors have become a little bit spooked by the rising number of coronavirus cases caused by the Delta Variant and, perhaps, panicked that a 1.1% drop in retail sales in July may be a sign of darker days ahead. Dan Kline is joined by Maxx Chatsko to explain what’s actually happening and why a little slowdown in consumer spending may actually benefit the market on the August 18 edition of “7investing Now.” Welcome to 7inve...
Aug 18, 2021•57 min•Season 2Ep. 119
Concerns are on high as the number of cases of the COVID Delta variant continues to rise, causing confusion for businesses, schools, and families. How is this looking in the United States, Australia, Canada, and several other nations? 7investing lead advisors Anirban Mahanti and Dana Abramovitz share the long-term business impacts of the Delta variant, how investors should calibrate their expectations, and why “convenience is key” going forward. Welcome to 7investing. We are here to empower you ...
Aug 17, 2021•18 min•Season 2Ep. 118
Low interest rates and skyrocketing housing prices have been raising the roof on the rental market. What impact will this have on the overall US economy? 7investing lead advisors Dan Kline and Maxx Chatsko share their thoughts. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe...
Aug 17, 2021•18 min•Season 2Ep. 117
The solid performance of Softbank’s legendary Vision Fund helped the company report record-breaking earnings earlier this year. But due to China’s unpredictable regulations, Softbank has now pulled the plug on all new investments in the country. Is China’s recent tech selloff a long-term opportunity, or is it a harbinger of more bad things to come? 7investing lead advisors Simon Erickson and Steve Symington discuss Softbank, China’s regulatory regime, and the difference between volatility and ri...
Aug 17, 2021•19 min•Season 2Ep. 116
Logistics may be one of the most important things you rarely think about. When you get two day, one day, or even same-day delivery, an awful lot of moving parts have to come together to make that happen. GXO Logistics (NYSE: GXO) will be one of the companies working behind the scenes to make the magic happen. Spun-off earlier this month from XPO Logistics (NYSE: XPO), a top ten global logistics provider of supply chain solutions to some of the most successful companies in the world, GXO will be ...
Aug 17, 2021•21 min•Season 2Ep. 115
Sometimes the best investment ideas come from companies seeking to disrupt well-entrenched industries. That, of course, isn’t easy to do because the establishment has a well-vested interest in protecting the status quo. Health care offers a lot of opportunity for disruption, but it also may come with as many roadblocks as any other area. Dana Abramowitz and Simon Erickson join Dan Kline for 7investing Now to dig into what’s happening in healthcare disruption and the forces disruptors are coming ...
Aug 16, 2021•48 min•Season 2Ep. 114
The House of Mouse reported its third-quarter earnings on August 12 and the numbers told a lot about where the company stands as parts of its business recover from the pandemic while other segments continue to (in some ways) benefit from it. It was a massive success for Disney which saw its business segment which includes its theme parks return to profitability and its streaming service continue to post incredible growth. Welcome to 7investing. We are here to empower you to invest in your future...
Aug 13, 2021•1 hr 1 min•Season 2Ep. 113
Long-term success in investing is about much more than just picking good stocks. There are several lurking landmines that could wreak havoc on our long-term investment returns. Emotional and unconscious biases often convince us to buy or sell great companies at exactly the wrong time. Ecstatic bubbles can pop and create panic-laden recessions, causing broader-market sell offs that torpedo entire sectors. And while they may be seldom-discussed and underappreciated, the cousins of risk and luck ha...
Aug 12, 2021•55 min•Season 2Ep. 112
There has been good news and bad news for American consumers. Wages, especially at the bottom end of the workforce have been rising, but those gains have seen their impact muted by price increases in a number of areas. Some have called this inflation, but it’s not that simple. While there likely is some inflation in the market, there are also clear supply chain issues that have driven up prices for cars, appliances, some electronics, and more. Maxx Chatsko joins Dan Kline on “7investing Now” liv...
Aug 11, 2021•53 min•Season 2Ep. 111
Fastly’s growth rates have come to a screeching halt, and its customers are infuriated over a recent network outage. Are these short-term blips that are correctable? Or are they indicative of longer-term problems with the company’s technology? 7investing lead advisors Anirban Mahanti and Dan Kline discuss Fastly’s Content Delivery Network and whether it is sustainable as a long-term investment. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best idea...
Aug 10, 2021•16 min•Season 2Ep. 110
After a disappointing first day of trading, Robinhood’s stock has regained confidence from investors. Is this just short-term noise, or are there important new developments that long-term investors should be aware of? 7investing lead advisors Dana Abramovitz and Steve Symington take a closer look at one of the stock market’s most recent IPOs. The two also dig into a new educational program that Target is offering to its employees. Welcome to 7investing. We are here to empower you to invest in yo...
Aug 10, 2021•16 min•Season 2Ep. 109
Simon Property Group has disclosed its sales have now fully recovered to their 2019 levels. Post-pandemic, what items are consumers most interested in buying from malls? 7investing lead advisors Dan Kline and Maxx Chatsko discuss why certain “A-List” malls could be lucrative long-term investment opportunities that are benefiting from pent-up demand. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for j...
Aug 10, 2021•16 min•Season 2Ep. 108
Square’s acquisition of Afterpay will give it access to the fast-growing Buy Now Pay Later market. Was this a good acquisition, or was the price tag too expensive? 7investing lead advisors Anirban Mahanti and Steve Symington discuss Square’s underappreciated network effects and why the company is so excited about integrating BNPL into its existing Cash App. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribe...
Aug 09, 2021•19 min•Season 2Ep. 106
Daniel Anstandig, the CEO and Co-Founder of Futuri -- an innovative company focusing on enhancing the effectiveness of media through an enterprise tech platform -- joined the 7investing podcast to explain what his company does and share his thoughts on the future of media. Futuri has targeted making content companies more effective. The emerging brand uses an artificial intelligence (AI) system to “detect stories bubbling to the surface that are going to go viral, allowing producers (podcasts, T...
Aug 05, 2021•32 min•Season 2Ep. 105
When Caribou Biosciences (NASDAQ: CRBU) became the seventh publicly-traded CRISPR stock in July 2021, I saw an exchange on social media. One person asked why the company sported a market valuation of $900 million when another newly-public CRISPR stock, Verve Therapeutics (NASDAQ: VERV), was valued near $2.3 billion. "Is there any reason for this other than the timing of the IPOs?", asked the individual. The thread received multiple responses confirming the seemingly large valuation difference be...
Aug 03, 2021•46 min•Season 2Ep. 104
Robinhood’s first day as a publicly-traded company didn’t quite go as planned. Is this company a long-term investment opportunity? 7investing lead advisors Dana Abramovitz and Simon Erickson analyze how Robinhood makes its money and whether those revenue streams are long-term sustainable. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward'...
Aug 02, 2021•15 min•Season 2Ep. 104
Markets have been propped up by low interest rates for quite some time, yet inflation looms on everyone’s mind. What could be the impact for long-term investors? 7investing lead advisors Maxx Chatsko and Steve Symington share their take on the Fed’s recent actions, the potential for transitory inflation, and certain pockets of the economy that are a bit ‘frothier’ than others. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock mar...
Aug 02, 2021•15 min•Season 2Ep. 102
The world is adjusting to the new normal of the COVID pandemic. But what could resurging cases of its Delta variant mean for the stock market? 7investing lead advisors Anirban Mahanti and Dan Kline evaluate the impact of the pandemic on companies with international supply chains and share their advice for long-term investors. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $39...
Aug 02, 2021•16 min•Season 2Ep. 101
China is threatening stricter regulations on its businesses who are listed on American exchanges. What could this mean for long-term investors? 7investing Lead Advisors Maxx Chatsko and Simon Erickson dig into variable interest entities, what it means to be ‘delisted’, and what China is ultimately trying to achieve on the global stage. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per mo...
Aug 02, 2021•23 min•Season 2Ep. 100
In a Sunday surprise Square reported its second quarter earnings and dropped the news that it will buy Australian buy-now-pay-later (BNPL) firm Afterpay for $29 billion. The all-stock transaction will give Afterpay shareholders 0.375 shares of Square class A stock for every share they own. That’s roughly a 30% premium from where shares closed at the end of the market day Friday. Anirban Mahanti and Simon Erickson join the Monday edition of 7investing Now to break down the deal and to explain wha...
Aug 02, 2021•53 min•Season 2Ep. 99
It has been a very busy earnings season and a lot of big tech companies have followed the same pattern -- report good, even great, numbers, then warn that the next quarter may see things slow down. That’s what happened with both Facebook and Amazon. The two companies ostensibly killed it, but they did warn that future growth won’t be as big. In addition, we’ll talk about whether Intel can complete its comeback and take on AMD in the fight for artificial intelligence dominance. Welcome to 7invest...
Jul 30, 2021•1 hr 2 min•Season 2Ep. 98
Finding a stock that returns 100 times your initial investment might sound like an improbable dream for most investors. After all, who would think that anyone could possibly turn $10,000 into $1 million with any reasonable degree of certainty? In fact, there are hundreds of stocks that have done exactly that in recent years. And anyone can find them if they know what to look for. In his book, “100 Baggers: Stocks That Return 100-to-1 and How To Find Them,” author, portfolio manager, and Woodlock...
Jul 29, 2021•47 min•Season 2Ep. 98
Tesla kicked off earnings season with some strong numbers despite having to manage supply chain issues related to the chip shortage. Apple followed that with some blockbuster numbers but shares in the tech giant fell because it warned that chip shortages could impact its iPhone output. Starbucks had a similar trajectory with the company delivering strong numbers but warning that it expects weakness in China in the next quarter. Microsoft closes out our quartet of companies with its own blockbust...
Jul 29, 2021•59 min•Season 2Ep. 96
The pandemic has come roaring back as the Delta variant of COVID-19 has led to a big increase in people being infected and hospitalizations in U.S. states with low vaccination levels. Does this pose a threat for the economy at large? Is it a bump in what has already been a bumpy road or something that could set the economy back to where it was during the worst of the pandemic? Maxx Chatsko joins Dan Kline to discuss how you should be viewing this as a long-term investor. Welcome to 7investing. W...
Jul 27, 2021•1 hr 2 min•Season 2Ep. 95
Both companies had impressive earnings and have performed well during the pandemic. The question -- and it’s one a lot of investors are asking -- is can both companies keep growing at the impressive rates they have been for a very long time (with one E-coli-related blip for Chipotle). Is there anything either chain needs to worry about and can investors still expect outsized returns given how well these stocks have been performing? Welcome to 7investing. We are here to empower you to invest in y...
Jul 23, 2021•48 min•Season 2Ep. 94
Mergers and acquisitions play a crucial role in the business world. Companies that combine forces can expand their overall book of business, execute in new markets, or serve new customer groups where they previously had no presence. The importance of M&A is even more pronounced in today's digital age. Popular websites, apps, or platforms can now serve hundreds of millions or even billions of users. Innovative technologies or new products can be infinitely scalable and quickly applied across ...
Jul 22, 2021•37 min•Season 2Ep. 93
Going public with less scrutiny can be a wonderful thing for some companies but scrutiny tnd to benefit investors. The SEC may be difficult to deal with, but the long road to a traditional IPO contains a lot of checks and balances that tend to make those deals more transparent. Simon Erickson joins Dan Kline on 7investing Now to discuss where SPACs stand, why the number of companies going public this way has slowed, and when/if investors should buy shares in companies that go public this way. We...
Jul 21, 2021•51 min•Season 2Ep. 92
Dr. Sandy Magnus has quite literally seen the world from a much higher point of view. As a former NASA astronaut, one who even lived four months on the International Space Station, she’s had a direct look for decades at the world’s most innovative technologies. She’s also a hero and an incredible role model to millions of people across our planet. But outer space is also capturing the imagination of the business world as well. Billionaire entrepreneurs are committing fortunes to launch companies...
Jul 20, 2021•20 min
Hitting a $100 billion valuation marks a major milestone for a drug company, but it has also been a mark that tends to be hard to grow beyond. For many drug makers, it has been sort of a hard wall, but there are reasons that may or may not be true for Moderna, according to Maxx Chatsko. In addition, Zoom spent $14.7 billion to buy Five9, an intelligent cloud contact center company. Steve Symington joins Maxx and Dan Kline to break down what the deal means. Welcome to 7investing. We are here to e...
Jul 19, 2021•1 hr 5 min•Season 2Ep. 90
